Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ivan Budnik

Showing results (51-60 of 66) with videos related to

Pageof 7
Sort By:
Pediatric Blood & Cancer|August 23, 2022
Application of a clinical decision rule and laboratory assays in pediatrics: Adult heparin-induced thrombocytopeniaOmri Cohen, Kfir Lange, Ivan Budnik, et al.
Blood Advances|January 9, 2025
Imbalanced VWF-ADAMTS13 axis contributes to the detrimental impact of a preceding respiratory tract infection on strokeRakesh B Patel, Abhishek B Jha, Aditi Jain, et al.
Pediatric Blood & Cancer|November 25, 2024
The Impact of Emicizumab Prophylaxis on Hospitalizations and Emergency Department Visits Among Hemophilia A Patients Is Age RelatedDan Geller, Ivan Budnik, Tlalit Barhod, et al.
Blood Cells, Molecules & Diseases|December 19, 2020
The potential role of emicizumab prophylaxis in severe von Willebrand diseaseAssaf A Barg, Einat Avishai, Ivan Budnik, et al.
Pediatric Blood & Cancer|October 23, 2025
Emicizumab in Previously Untreated Patients and Minimally Treated Patients With Hemophilia A: A Comparative Study Between Two International CohortsSarina Levy-Mendelovich, Tlalit Barhod, Ivan Budnik, et al.
Biomolecules|March 3, 2021
Activated Protein C (APC) and 3K3A-APC-Induced Regression of Choroidal Neovascularization (CNV) Is Accompanied by Vascular Endothelial Growth Factor (VEGF) ReductionTami Livnat, Yehonatan Weinberger, José A Fernández, et al.
International Journal of Molecular Sciences|July 14, 2023
3K3A-Activated Protein C Inhibits Choroidal Neovascularization Growth and Leakage and Reduces NLRP3 Inflammasome, IL-1β, and Inflammatory Cell Accumulation in the RetinaYehonatan Weinberger, Ivan Budnik, Yael Nisgav, et al.
International Journal of Molecular Sciences|November 26, 2022
3K3A-Activated Protein C Prevents Microglia Activation, Inhibits NLRP3 Inflammasome and Limits Ocular InflammationDahlia Palevski, Gil Ben-David, Yehonatan Weinberger, et al.
Pediatric Blood & Cancer|November 17, 2023
Bleeding phenotype and hemostatic evaluation by thrombin generation in children with Noonan syndrome: A prospective studyAssaf A Barg, Yonatan Yeshayahu, Einat Avishai, et al.
Journal of Thrombosis and Haemostasis : JTH|November 20, 2025
Endothelial protein C receptor-mediated endogenous and therapeutic transport of activated protein C across the blood-retina barrier protects the retinaTami Livnat, Ivan Budnik, Yael Nisgav, et al.
Pageof 7

Showing results (51-60 of 66) with videos related to

Sort By:
Pageof 7
Pediatric Blood & Cancer|August 23, 2022
Application of a clinical decision rule and laboratory assays in pediatrics: Adult heparin-induced thrombocytopeniaOmri Cohen, Kfir Lange, Ivan Budnik, et al.
Blood Advances|January 9, 2025
Imbalanced VWF-ADAMTS13 axis contributes to the detrimental impact of a preceding respiratory tract infection on strokeRakesh B Patel, Abhishek B Jha, Aditi Jain, et al.
Pediatric Blood & Cancer|November 25, 2024
The Impact of Emicizumab Prophylaxis on Hospitalizations and Emergency Department Visits Among Hemophilia A Patients Is Age RelatedDan Geller, Ivan Budnik, Tlalit Barhod, et al.
Blood Cells, Molecules & Diseases|December 19, 2020
The potential role of emicizumab prophylaxis in severe von Willebrand diseaseAssaf A Barg, Einat Avishai, Ivan Budnik, et al.
Pediatric Blood & Cancer|October 23, 2025
Emicizumab in Previously Untreated Patients and Minimally Treated Patients With Hemophilia A: A Comparative Study Between Two International CohortsSarina Levy-Mendelovich, Tlalit Barhod, Ivan Budnik, et al.
Biomolecules|March 3, 2021
Activated Protein C (APC) and 3K3A-APC-Induced Regression of Choroidal Neovascularization (CNV) Is Accompanied by Vascular Endothelial Growth Factor (VEGF) ReductionTami Livnat, Yehonatan Weinberger, José A Fernández, et al.
International Journal of Molecular Sciences|July 14, 2023
3K3A-Activated Protein C Inhibits Choroidal Neovascularization Growth and Leakage and Reduces NLRP3 Inflammasome, IL-1β, and Inflammatory Cell Accumulation in the RetinaYehonatan Weinberger, Ivan Budnik, Yael Nisgav, et al.
International Journal of Molecular Sciences|November 26, 2022
3K3A-Activated Protein C Prevents Microglia Activation, Inhibits NLRP3 Inflammasome and Limits Ocular InflammationDahlia Palevski, Gil Ben-David, Yehonatan Weinberger, et al.
Pediatric Blood & Cancer|November 17, 2023
Bleeding phenotype and hemostatic evaluation by thrombin generation in children with Noonan syndrome: A prospective studyAssaf A Barg, Yonatan Yeshayahu, Einat Avishai, et al.
Journal of Thrombosis and Haemostasis : JTH|November 20, 2025
Endothelial protein C receptor-mediated endogenous and therapeutic transport of activated protein C across the blood-retina barrier protects the retinaTami Livnat, Ivan Budnik, Yael Nisgav, et al.
Pageof 7